Multiple Sclerosis (MS): Testing and Therapeutic Options

Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system related to infections such as Epstein-Barr Virus (EBV) and Borreliosis infections. Specialised labs such as ArminLabs offers specific tests panels for MS and can help you find clinics that offer treatments for MS.

Treatment of Infections Associated with Multiple Sclerosis (MS)

Infections, such as Epstein-Barr Virus and Borrelia infections, can be general protocols or with precision treatments such as Supportive Oligonucleotide Therapy, SOT.

SOT is still in development and is only offered in specialised clinics.

SilentGene offer MS test panels from ArminLabs, a leading European pathogen test lab.

Below is an example of test panel is designed by ArminLabs to indicate infections caused by pathogens associated to Multiple Sclerosis (MS)* and not as a tool to diagnose Multiple Sclerosis (MS).

This test panel includes:

  • Borrelia EliSpot*

  • CD3-/CD57+/CD56+/CD45+ Cells

  • Borrelia IgG-/IgM-SeraSpot®

  • Bartonella henselae EliSpot

  • Bartonella IgG-antibodies (hens.+quint.)

  • Bartonella IgM-antibodies (hens.+quint.)

  • Chlamydia pneumoniae EliSpot

  • Chlamydia pneumoniae IgG-/IgA-antibodies

  • Mycoplasma pneumoniae EliSpot

  • Mycoplasma pneumoniae IgG-/IgA-antibodies

  • EBV EliSpot (2 antigens: lytic+latent)

  • EBV IgG-/IgM-/EBNA-antibodies

  • HSV 1/2 EliSpot

  • HSV 1/2  IgG-/IgA-/IgM-antibodies

  • CMV EliSpot (2 antigens: lytic+latent)

  • CMV IgG-/IgM-antibodies

  • VZV EliSpot

  • VZV IgG-/IgA-/IgM-antibodies

  • Coxsackievirus A7/B1 IgG-/IgA-antibodies

  • HHV 6 IgG-/IgM-antibodies)

*Positive test results only indicates an ongoing infection and not causality regrading any condition. Please consult medical professionals for analyse of test results.

Infection association with Multiple Sclerosis (MS)

There are a number of studies that shows an association between infections and Multiple sclerosis (MS)

1988 Dr. Vincent Marshall ‘s exhaustive research from the 80’s showed spirochetes on the axons of nerves of MS patient autopsies in Europe.

2004 Markus Fritzsche found chronic Lyme borreliosis at the root of multiple sclerosis.

2017 Annette Langer-Gould found that Epstein-Barr was independently associated with an increased odds of MS/CIS in 3 racial/ethnic groups.

2022 a study led by Harvard T.H. Chan School of Public Health researchers found the first compelling evidence that MS is likely caused by infection with the Epstein-Barr virus

2022 Kjetil Bjornevik et al published a study using data from more than ten million United States military recruits monitored over a 20-year period, 955 of whom were diagnosed with MS during their service, Kjetil Bjornevik et al. tested the hypothesis that MS is caused by EBV. They found that the risk of developing MS in individuals who were EBV- negative increased by 32-fold following EBV infection

2023 Researchers at Karolinska Institutet found further evidence for how the Epstein-Barr virus can trigger multiple sclerosis or drive disease progression. A study published in Science Advances shows that some individuals have antibodies against the virus that mistakenly attack a protein in the brain and spinal cord.

“My friend helped me find a treatment in Germany that cured me from a borrelia infection after 14 years of chronic infection. With Infection Sherpa I hope to help others find help just as I did”

— Harald Hynell, co-founder of Infection Sherpa